Results 31 to 40 of about 609 (139)

Pachychoroid, an update from the new finding to the usual investigation in selected diseases

Revista Brasileira de Oftalmologia
The authors make an update of pachychoroid in a group of the choroidal-retinal diseases that choroidal thickening is an usualenhanced depth image - optic coherence tomography (EDI-OCT) finding like as central serous chorioretinopathy, pachychoroid ...
Miguel Hage Amaro, Jorge Mitre, Mario Martins dos Santos Motta, João Jorge Nassaralla Junior, Teruo Aihara   +4 more
doaj   +2 more sources

Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration [PDF]

Scientific Reports, 2023
To determine the clinical properties of pachychoroid neovasculopathy (PNV) that differ from conventional neovascular age-related macular degeneration (nAMD) and suggest that they are different clinical entities.
Ai Kuranami, Ruka Maruko, Ichiro Maruko, Taiji Hasegawa, Tomohiro Iida   +4 more
doaj   +2 more sources

Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment [PDF]

Scientific Reports, 2023
To compare the choroidal neovascular features of individuals with pachychoroid neovasculopathy (PNV) and neovascular age-related macular degeneration (nAMD) with and without shallow irregular pigment epithelial detachment (SIPED). Using optical coherence
Hamid Riazi-Esfahani, Esmaeil Asadi Khameneh, Fariba Ghassemi, Mohammadreza Mehrabi Bahar, Ali torkashvand, Alireza Mahmoudi, Ahmed Husein Ahmed, Shahin Faghihi, Masoud Rahimi, Ali Akbarzadeh, Hooshang Faghihi, Elias Khalili Pour   +11 more
doaj   +2 more sources

The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy.

PLoS ONE, 2019
Pachychoroid neovasculopathy (PNV) shares some anatomical features with other pachychoroid spectrum diseases, but little is known about the characteristics on the treatment with anti-vascular endothelial growth factor (VEGF).
Keiko Azuma, Xue Tan, Shotaro Asano, Kimiko Shimizu, Asako Ogawa, Tatsuya Inoue, Hiroshi Murata, Ryo Asaoka, Ryo Obata   +8 more
doaj   +2 more sources

Understanding the relationship between pachychoroid spectrum disorders and retinitis pigmentosa: A review of the evidence

Indian Journal of Ophthalmology
This study aims to investigate the relationship between pachychoroid spectrum disorders and retinitis pigmentosa (RP) or rod-cone dystrophy through a comprehensive literature review.
Kasturi Chavan, Jay Chhablani, Subhadra Jalali, Srikanta Kumar Padhy   +3 more
doaj   +2 more sources

Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept. [PDF]

Sci Rep, 2020
AbstractNon-response to intravitreal ranibizumab represents a frequent problem in pachychoroid neovasculopathy (PNV). To investigate the effectivity of switching to aflibercept, the database of the Ludwig Maximilians University, Munich, was screened for patients fulfilling the following inclusion criteria: (i) diagnosis of PNV; (ii) inadequate response
Schworm B, Luft N, Keidel LF, Herold TR, Wolf A, Priglinger SG, Siedlecki J.   +6 more
europepmc   +7 more sources

Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy [PDF]

Case Reports in Ophthalmology, 2021
Nonresponse of neovascular age-related macular degeneration (nAMD) to anti-vascular endothelial growth factor (anti-VEGF) therapy can often be attributed to misdiagnosis, and pathologies mimicking AMD might require different therapeutic concepts.
Leonie F. Keidel, Benedikt Schworm, Siegfried G. Priglinger, Jakob Siedlecki   +3 more
doaj   +2 more sources

Short-term outcomes and choroidal morphological changes following aflibercept therapy in pachychoroid neovasculopathy [PDF]

Scientific Reports
To evaluate the short-term outcomes and choroidal morphological changes after three monthly aflibercept injections for pachychoroid neovasculopathy (PNV).
Jae Hui Kim, Sang Min Park, Soon Il Choi, Dong Ik Kim, Joonhong Sohn, Won Ki Lee   +5 more
doaj   +2 more sources

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy [PDF]

Scientific Reports, 2021
To compare the long-term effectiveness of intravitreal anti-vascular endothelial growth factor (VEGF) treatment for pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1), and typical ...
Jihyun Yoon, Wontae Yoon, Seung kwan Na, Jihyun Lee, Chul Gu Kim, Jong Woo Kim, Han Joo Cho   +6 more
doaj   +2 more sources

Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy [PDF]

Clinical Ophthalmology, 2021
Takamasa Kinoshita, Junya Mori, Akira Hatanaka, Miho Shimizu, Hiroko Imaizumi Department of Ophthalmology, Sapporo City General Hospital, Sapporo, JapanCorrespondence: Takamasa KinoshitaDepartment of Ophthalmology, Sapporo City General Hospital, 1-1, N ...
Kinoshita T, Mori J, Hatanaka A, Shimizu M, Imaizumi H   +4 more
doaj   +2 more sources